Clarity Pharmaceuticals Ltd (ASX:CU6)
Australia · Delayed Price · Currency is AUD 3.800
-0.110 (-2.81%)
At close: Jan 9, 2026
Clarity Pharmaceuticals Market Cap
Clarity Pharmaceuticals has a market cap or net worth of 1.41 billion as of January 9, 2026. Its market cap has increased by 3.69% in one year.
Market Cap
1.41B
Enterprise Value
1.33B
Revenue
9.46M
Ranking
n/a
PE Ratio
n/a
Stock Price
3.80
Market Cap Chart
Since August 25, 2021, Clarity Pharmaceuticals's market cap has increased from 384.20M to 1.41B, an increase of 267.96%. That is a compound annual growth rate of 34.66%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 9, 2026 | 1.41B | 12.43% |
| Dec 31, 2025 | 1.26B | -6.00% |
| Dec 31, 2024 | 1.34B | 168.49% |
| Dec 29, 2023 | 498.26M | 93.82% |
| Dec 30, 2022 | 257.07M | 35.63% |
| Dec 31, 2021 | 189.54M | -50.67% |
| Aug 25, 2021 | 384.20M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CSL Limited | 84.03B |
| Pro Medicus | 21.96B |
| Cochlear | 17.22B |
| Sonic Healthcare | 11.07B |
| Ramsay Health Care | 8.13B |
| Ansell | 4.77B |
| Mesoblast | 3.94B |
| Telix Pharmaceuticals | 3.81B |